Acevedo, S. F., Fujiwara, S., Akahata, W., Baik, F., Le, Q. X., Colevas, A. D., Smith, J., Pham, N., Rahman, M., Ishikawa, M., Bowling, F., Park, T., Matsuda, K. (2026). Phase 1 study of VLPONC-01, a novel IL-12–encoding saRNA viral replicon particle, alone and in combination with pembrolizumab in head and neck cancer patients: Protocol summary.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps6134